Veradermics
MANE | NYSE
$133.22
-$6.47 (-4.63%)
Nov 2, 2026, 11:01 AM ET · Market open
TTM Period Ending | TTM 2026 Jun 30, 2026 | TTM 2026 Mar 31, 2026 | TTM 2025 Dec 31, 2025 | TTM 2025 Sep 30, 2025 | TTM 2024 Dec 31, 2024 | TTM 2023 Dec 31, 2023 |
|---|---|---|---|---|---|---|
PE Ratio | -57.45 | -40.48 | -15.86 | n/a | -269.64 | -460.93 |
PEG Ratio | 2.09 | -7.69 | -0.01 | n/a | -3.80 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 6.11 | 6.02 | -10.94 | n/a | 139.04 | 519.93 |
P/FCF Ratio | -63.47 | -36.95 | -18.49 | n/a | -320.85 | -562.57 |
P/OCF Ratio | -63.49 | -36.95 | -18.49 | n/a | -320.85 | -562.57 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | n/a | 0 | 0 | n/a | 0.05 |
Quick Ratio | 70.53 | 59.12 | 16.66 | 3.29 | 11.77 | 5.75 |
Current Ratio | 70.53 | 59.12 | 16.66 | 3.29 | 11.77 | 5.75 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -193.18 | -137.63 | n/a | -90.13 | -45.77 | -481.22 |
Return on Equity | -37.51% | -118.71% | 57.84% | 10.58% | -48.46% | -112.81% |
Return on Assets | -11.22% | -17.36% | -45.86% | -137.06% | -44.61% | -89.35% |
Return on Invested Capital | -9.97% | -14.76% | -50.43% | -158.68% | -48.99% | -112.46% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MANE